Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
View the Guide
Featured Profiles
Geron
SpringWorks/EMD Serono
Syndax Pharmaceuticals
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
DLBCL Download: Emerging Insights From ASCO 2026
OFS Summit
Multimedia
All Videos
Cancer, Clearly
Case-Based Exchanges
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
View the Guide
Featured Profiles
Geron
SpringWorks/EMD Serono
Syndax Pharmaceuticals
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
DLBCL Download: Emerging Insights From ASCO 2026
OFS Summit
Multimedia
All Videos
Cancer, Clearly
Case-Based Exchanges
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Steven Selde
Director
Biosimilars Council, a Division of the Association for Accessible Medicines Pharmaceutical Manufacturing
Washington, DC
Authored Items
HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use
By
Steven Selde
May 2022, Vol 12, No 5
Biosimilars
Biosimilars provide more options for care at a lower cost for patients, but due to Medicare’s perverse incentives, many pharmacy benefit managers and health plans have been slow to prioritize biosimilars, leaving savings on the table.
Read More ›